Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Codagenix announces the initiation of first in human study of COVI-VAC in the U.K.

Dec. 16, 2020

InvisiMask human antibody nasal spray protects against SARS-CoV-2 infection in vivo

Dec. 15, 2020

AB-729 results in robust reduction in HBsAg in patients with chronic hepatitis B

Dec. 15, 2020

CureVac initiates pivotal phase IIb/III study of CVnCoV

Dec. 15, 2020

Phase III study of ruxolitinib in COVID-19 does not meet primary endpoint

Dec. 14, 2020

Amarin reports data on Vascepa in COVID-19 outpatients

Dec. 14, 2020

Italian researchers identify new compounds for HBV infection

Dec. 14, 2020

Cadila Healthcare discloses new compounds for tuberculosis

Dec. 14, 2020

Tychan to initiate phase III study of TY-027 in patients with COVID-19

Dec. 14, 2020

Preliminary clinical data for proxalutamide in COVID-19

Dec. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.